CEA Antibody / Carcinoembryonic Antigen

NSJ Bioreagents
Product Code: NSJ-V2089IHC
Product Group: Primary Antibodies
Supplier: NSJ Bioreagents
CodeSizePrice
NSJ-V2089IHC-7ML7 ml£534.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Mouse
Antibody Isotype: Mouse IgG1 kappa
Antibody Clonality: Monoclonal
Antibody Clone: CEA31
Regulatory Status: RUO
Target Species: Human
Application: Immunohistochemistry- Paraffin Embedded (IHC-P)
Storage:
Store the CEA antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).

Images

1 / 4
IHC testing of FFPE human colon carcinoma stained with CEA antibody (clone CEA31).
2 / 4
IHC testing of FFPE human colon carcinoma stained with CEA antibody (clone CEA31).
3 / 4
IHC testing of FFPE human colon carcinoma stained with CEA antibody (clone CEA31).
4 / 4
SDS-PAGE analysis of purified, BSA-free CEA antibody (clone CEA31) as confirmation of integrity and purity.

IHC testing of FFPE human colon carcinoma stained with CEA antibody (clone CEA31).
IHC testing of FFPE human colon carcinoma stained with CEA antibody (clone CEA31).
IHC testing of FFPE human colon carcinoma stained with CEA antibody (clone CEA31).
SDS-PAGE analysis of purified, BSA-free CEA antibody (clone CEA31) as confirmation of integrity and purity.

Documents

Further Information

Application Details:
The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.
Application Note:
The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the antibody to be titered up or down for optimal performance.

1. Staining of formalin-fixed tissues requires boiling tissue sections in pH 9 10mM Tris with 1mM EDTA for 10-20 min followed by cooling at RT for 20 minutes.
2. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.

Description:
This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.
Format:
Purified
Formulation:
Prediluted in 1X PBS with 0.1 mg/ml BSA (US sourced) and 0.05% sodium azide; *For IHC use only*
Immunogen:
Human colon carcinoma extract was used as the immunogen for this antibody.
Limitation:
This CEA antibody is available for research use only.
Localization:
Cytoplasmic and luminal surface
Purity:
Protein G affinity chromatography
Uniprot #:
P06731